A novel technological breakthrough presented by researchers at the European Molecular Biology Laboratory (EMBL) now promises to revolutionize how scientists decode these protein-ligand interactions on a massive scale. In a recent study published in Nature Structural and Molecular Biology, the Savitski Group at EMBL unveiled HT-PELSA, a high-throughput peptide-centric local stability assay. This method not only scales up the classical PELSA workflow but also enhances sensitivity and applicability, allowing the exploration of protein-ligand engagements directly in complex biological mixtures such as crude cell lysates, tissues, and bacteria—a feat previously unattainable with traditional techniques.

The original PELSA methodology emerged only last year as an innovative technique to detect protein-ligand binding events by monitoring local changes in protein stability upon ligand association. Binding typically stabilizes specific protein regions against enzymatic cleavage by proteases such as trypsin, resulting in changes in the abundance of peptide fragments from those regions. Tracking such subtle alterations across the entire proteome allowed researchers to identify previously elusive binding hotspots with remarkable peptide-level resolution. However, PELSA’s labor-intensive nature restricted it to processing only a limited number of samples daily, imposing significant bottlenecks on throughput and sample diversity.

HT-PELSA brilliantly addresses these limitations through a radical shift in sample handling format, transitioning from traditional tubes to a 96-well plate micro-well system optimized for automation. This transformation enables robotic handling and parallel processing of hundreds of samples simultaneously, exponentially boosting throughput without compromising the exquisite sensitivity that made PELSA powerful. As Kejia Li, the pioneering postdoctoral fellow who spearheaded the adaptation at EMBL, explains, this newly developed workflow now allows the analysis of roughly 400 samples per day, compared to a mere 30 with the original method—a remarkable fifteenfold increase in efficiency.

At the core of HT-PELSA’s enhanced workflow lies an ingenious exploitation of the hydrophobic and water-repellant characteristics of proteins relative to their peptide fragments. While trypsin digestion retains its fundamental role, HT-PELSA leverages a novel protein-adsorption surface, which preferentially captures intact proteins while allowing cleaved peptides to remain in solution. This physical separation streamlines sample processing and, crucially, opens the door to investigating membrane proteins—a notoriously difficult class to analyze. Membrane proteins comprise about 60% of all known drug targets and their delicate structures often render them incompatible with conventional methods requiring harsh extraction and purification, which can alter their native conformations.

By enabling the direct study of protein-ligand binding events in unpurified complex biological samples, HT-PELSA offers unprecedented insights into physiologically relevant interactions. This method preserves the native environment of membrane proteins and other challenging targets, allowing researchers to observe how candidate drugs or endogenous molecules engage these proteins under biologically realistic conditions. Such capability is vital for drug discovery pipelines, where understanding the binding specificity and mechanistic impact of small molecules on their intended targets can dramatically improve target validation and lead optimization.

Isabelle Becher, a key contributor to the project and laboratory officer in charge at EMBL’s Savitski Group, emphasizes the profound biological understanding HT-PELSA provides. The method charts an expansive landscape of protein-ligand interactions by revealing dynamic changes in local stability patterns across thousands of proteins simultaneously. This holistic view enhances the ability to decipher underlying molecular mechanisms governing cellular processes and pathologies. Furthermore, identifying selective interactions aids in the rational design of therapeutics tailored to precise protein targets, improving efficacy while minimizing off-target effects, thus advancing safer and more effective medicines.

In addition to its primary focus on ligand binding, the current study showcases HT-PELSA’s capacity to detect modifications in protein-protein interactions induced by ligand association. This dual-sensitivity highlights the method’s versatility in capturing the wider network of molecular interactions that define cellular states and responses. Looking forward, the researchers intend to extend HT-PELSA’s application to assess protein-nucleic acid interactions, further expanding its utility in elucidating the molecular architecture and functional circuitry of cells.

Mikhail Savitski, team leader at EMBL Heidelberg and senior author of the study, remarks that HT-PELSA is a transformative step in proteomics technology, significantly accelerating both fundamental research and applied biomedical science. Beyond its immediate role in protein function characterization, HT-PELSA’s scalability and robustness position it as a cornerstone platform capable of driving large-scale drug screening campaigns. Its integration with advanced mass spectrometry and bioinformatics workflows promises to usher in a new era of molecular precision medicine.

This advancement holds particular promise for the pharmaceutical industry and academic researchers alike. The ability to swiftly assess hundreds of drug candidates across diverse protein targets, including integral membrane components often overlooked previously, represents a monumental stride toward combating complex diseases. Simultaneously, it equips biologists with a powerful tool to dissect proteome dynamics in various tissues and organisms, facilitating a deeper grasp of biology from a systems-level perspective.

In summary, HT-PELSA marks a milestone in the ongoing quest to decode the intricacies of protein-ligand interactions at an unprecedented scale and depth. By marrying the finesse of the original PELSA assay with automation and novel biochemical innovations, this cutting-edge technology unlocks access to challenging protein classes and complex biological samples. It stands as a shining example of how marrying technological ingenuity with biological insight can create transformative tools, primed to accelerate the discovery and optimization of next-generation drugs while enriching our fundamental understanding of life’s molecular underpinnings.

Subject of Research: Protein-ligand interactions; high-throughput proteomics; membrane proteins; drug discovery

Article Title: High-throughput peptide-centric local stability assay extends protein–ligand identification to membrane proteins, tissues and bacteria

News Publication Date: 5-Nov-2025

Web References: 10.1038/s41594-025-01699-y

Image Credits: Daniela Velasco/EMBL

Keywords: Molecular evolution, Proteomics

At the heart of this technological breakthrough lies the principle of solid-state nanopores—nanoscale holes embedded in thin membranes that serve as portals through which individual biomolecules such as proteins translocate. As these molecules pass through the nanopores, they transiently disrupt an ionic current, generating electrical signatures that reflect their physical and chemical properties. While nanopore sensing has revolutionized nucleic acid sequencing by reading the DNA and RNA sequences directly, its application to proteins has been substantially more complicated. Proteins exhibit a more diverse and dynamic range of conformations compared to nucleic acids, leading to signals that are both complex and variable, thereby complicating their direct interpretation.

To overcome the inherent limitations of single-voltage nanopore measurements traditionally employed, the researchers devised a strategy of systematically varying the transmembrane voltage applied during molecular translocation. This multivoltage approach produces a rich dataset of signal responses under different electrical driving forces, capturing both stable and voltage-dependent molecular behaviors. By compiling these distinct signal patterns into a structured voltage matrix, the team unlocks a multidimensional profile of each protein’s electrical fingerprint. This matrix serves as an input for sophisticated machine learning models, which classify and discriminate proteins with remarkable accuracy, even amidst intricate mixtures.

The experimental rigor of this novel methodology was demonstrated on biologically significant cancer biomarkers—carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3). These proteins, pivotal in cancer diagnostics, were analyzed both in isolation and as components of mixed samples. By recording nanopore signals under six discrete voltage settings, distinct electrical response profiles were identified that uniquely correspond to each protein. Notably, the method could detect molecular population shifts upon the binding of an aptamer, a synthetic DNA sequence that selectively interacts with CEA, underscoring the sensitivity of the voltage-matrix approach to subtle molecular modifications.

Beyond purified protein mixtures, the researchers extended their investigation to biologically complex fluids such as mouse serum. Through comparative analysis of serum samples subjected to centrifugation versus untreated controls, the voltage-matrix framework was capable of distinguishing nuanced compositional changes induced by sample processing. This pivotal result underscores the technique’s robustness and its potential utility in analyzing real-world clinical and environmental specimens, where molecular heterogeneity often confounds conventional analytical methods.

Professor Sotaro Uemura, leading the initiative at the University of Tokyo’s Department of Biological Sciences, emphasized the transformative potential of integrating multivoltage nanopore sensing with machine learning. “Our methodology transcends traditional protein detection by systematically exploring the voltage-dependent electrical landscape of biomolecules,” he explained. “The voltage matrix not only captures inherent, voltage-invariant features but also reveals subtle structural dynamics responsive to changes in the electric field, enabling a comprehensive representation of molecular individuality.”

This advancement ushers in a new paradigm where nanopore technology evolves from a nucleic acid sequencing tool into a versatile platform for general molecular profiling. The capacity to visualize and quantify the compositional complexity of protein mixtures without reliance on labels or chemical modifications heralds a significant leap forward in bioanalytical science. Such a label-free, high-precision approach holds promise for accelerating biomarker discovery, enhancing diagnostic accuracy, and facilitating personalized medicine.

From a technical perspective, the voltage-matrix nanopore profiling technique capitalizes on the interplay between applied voltage and molecular conformation dynamics. By recording ionic current disruptions over a spectrum of transmembrane potentials, the system effectively probes different energetic states and interactions of the molecules inside the nanopore. This multidimensional data matrix enriches feature extraction processes integral to the machine learning classifiers, thus refining their discriminatory power.

Looking ahead, the research team envisions scaling and parallelizing this platform to enable real-time and multiplexed molecular profiling. By integrating arrays of nanopores operating under tailored voltage sequences, simultaneous analysis of multiple targets could be realized, dramatically increasing throughput and diagnostic relevance. Such innovations may ultimately contribute to the development of portable, rapid diagnostic devices for clinical settings, environmental monitoring, and beyond.

The implications of this research extend far beyond immediate protein detection. Voltage-matrix nanopore profiling illuminates the pathway toward understanding molecular individuality at unprecedented resolution. By facilitating the characterization of subtle structural variants and complex mixture compositions, the technology could impact a broad range of disciplines, including immunology, pharmacology, and proteomics. Moreover, it could catalyze new insights into disease mechanisms where protein heterogeneity plays a critical role.

In summary, this breakthrough from the University of Tokyo embodies a confluence of nanotechnology, electrical engineering, and artificial intelligence, culminating in a novel analytical framework that promises to redefine molecular diagnostics. With its capacity to discern complex protein mixtures sensitively and accurately, voltage-matrix nanopore profiling stands poised to become an indispensable tool in the scientific and medical toolbox, heralding a new era of molecular discernment and diagnostic precision.

Subject of Research:
Voltage-matrix nanopore profiling and machine learning-based classification of proteins in complex mixtures.

Article Title:
Voltage-matrix nanopore profiling for the discrimination of protein mixtures

News Publication Date:
6 October 2025

Web References:
http://dx.doi.org/10.1039/D5SC05182G

References:
Ryo Akita, Artem Lysenko, Keith A. Boroevich, Tatsuya Yokota, Daiki Kawai, Ryo Iizuka, Tatsuhiko Tsunoda and Sotaro Uemura, “Voltage-matrix nanopore profiling for the discrimination of protein mixtures,” Chemical Science, October 6, 2025, DOI: 10.1039/D5SC05182G

Image Credits:
Sotaro Uemura, The University of Tokyo

Keywords

Nanopore sensing, solid-state nanopores, protein profiling, voltage-matrix, machine learning, biomarker detection, molecular diagnostics, cancer biomarkers, molecular individuality, label-free analysis, nanopore technology, ionic current signatures